由于与 Masimo 的专利纠纷，Apple Watch Series 9 和 Ultra 2 在美国的血氧功能面临 2028 年的等待。 Apple Watch Series 9 and Ultra 2 in US face a 2028 wait for blood oxygen feature due to patent dispute with Masimo.
由于与 Masimo 的专利纠纷，美国 Apple Watch Series 9 和 Ultra 2 用户的血氧功能可能面临 2028 年的等待。 Apple Watch Series 9 and Ultra 2 users in the US may face a 2028 wait for the blood oxygen feature due to a patent dispute with Masimo. 苹果被迫在这些型号中禁用脉搏血氧仪，美国海关和边境保护局也禁止进口带有该功能的产品。 Apple was forced to disable pulse oximetry in these models, and the US Customs and Border Protection banned importing them with the feature. Apple 通过软件禁用了该功能，但可以通过未来的更新重新引入该功能，等待上诉或 2028 年 8 月专利到期。 Apple disabled the feature through software but can reintroduce it via a future update, pending an appeal or patent expiry in August 2028.